| Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo LX Shao, C Liao, I Gregg, PA Davoudian, NK Savalia, K Delagarza, ... Neuron 109 (16), 2535-2544. e4, 2021 | 623 | 2021 |
| Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin PA Davoudian, LX Shao, AC Kwan ACS Chemical Neuroscience 14 (3), 468-480, 2023 | 131 | 2023 |
| A dendrite-focused framework for understanding the actions of ketamine and psychedelics NK Savalia, LX Shao, AC Kwan Trends in Neurosciences 44 (4), 260-275, 2021 | 122 | 2021 |
| Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis X Liu, L Yang, L Shao, Y He, G Wu, Y Bao, N Lu, D Gong, Y Lu, T Cui, ... Journal of Experimental Medicine 217 (1), e20180992, 2019 | 74 | 2019 |
| A fluorogenic probe for ultrafast and reversible detection of formaldehyde in neurovascular tissues XG Liang, B Chen, LX Shao, J Cheng, MZ Huang, Y Chen, YZ Hu, YF Han, ... Theranostics 7 (8), 2305, 2017 | 52 | 2017 |
| Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors LX Shao, C Liao, PA Davoudian, NK Savalia, Q Jiang, C Wojtasiewicz, ... Nature, 1-10, 2025 | 45 | 2025 |
| Endogenous polysialic acid based micelles for calmodulin antagonist delivery against vascular dementia XJ Wang, YP Gao, NN Lu, WS Li, JF Xu, XY Ying, G Wu, MH Liao, C Tan, ... ACS applied materials & interfaces 8 (51), 35045-35058, 2016 | 34 | 2016 |
| Inhibitory regulation of calcium transients in prefrontal dendritic spines is compromised by a nonsense Shank3 mutation F Ali, LX Shao, DM Gerhard, K Sweasy, S Pothula, C Pittenger, ... Molecular psychiatry 26 (6), 1945-1966, 2021 | 33 | 2021 |
| Functional coupling of Tmem74 and HCN1 channels regulates anxiety-like behavior in BLA neurons LX Shao, Q Jiang, XX Liu, DM Gong, YX Yin, G Wu, NH Sun, CK Wang, ... Molecular psychiatry 24 (10), 1461-1477, 2019 | 25 | 2019 |
| A fluorogenic probe for imaging protein S-nitrosylation in live cells S Shao, B Chen, J Cheng, C Wang, Y Zhang, L Shao, Y Hu, Y Han, F Han, ... Biosensors and Bioelectronics 94, 162-168, 2017 | 23 | 2017 |
| Conformational restraint as a strategy for navigating towards lysosomes XG Liang, J Cheng, S Qin, LX Shao, MZ Huang, G Wang, Y Han, F Han, ... Chemical Communications 54 (85), 12010-12013, 2018 | 20 | 2018 |
| Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression F Aboharb, PA Davoudian, LX Shao, C Liao, GN Rzepka, C Wojtasiewicz, ... Nature Communications 16 (1), 1590, 2025 | 17 | 2025 |
| Cholinergic Grb2-associated-binding protein 1 regulates cognitive function NN Lu, C Tan, NH Sun, LX Shao, XX Liu, YP Gao, RR Tao, Q Jiang, ... Cerebral Cortex 28 (7), 2391-2404, 2018 | 14 | 2018 |
| Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug action LX Shao, C Liao, PA Davoudian, NK Savalia, Q Jiang, C Wojtasiewicz, ... biorxiv, 2024 | 5 | 2024 |
| Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks Q Jiang, LX Shao, S Yao, NK Savalia, AD Gilbert, PA Davoudian, ... Cell, 2025 | 2 | 2025 |
| Selective inhibition of Tmem74 expression in BLA pyramidal neurons LX Shao, Q Jiang, XX Liu, DM Gong, YX Yin, G Wu, NH Sun, CK Wang, ... Molecular Psychiatry 24 (10), 1399-1399, 2019 | 1 | 2019 |
| Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors LX Shao, C Liao, PA Davoudian, NK Savalia, Q Jiang, C Wojtasiewicz, ... Nature 646 (8087), E33, 2025 | | 2025 |
| The neurons that mediate a psychedelic's long-term antidepressive effects LX Shao, AC Kwan NATURE, 2025 | | 2025 |
| INTERNEURON CELL CLASS SPECIFIC CIRCUIT INFLUENCES ON THE ACTION OF PSILOCYBIN P Davoudian, N Savalia, C Liao, LX Shao, J Nothnagel, T Sakurai, ... NEUROPSYCHOPHARMACOLOGY 49, 471-472, 2024 | | 2024 |
| Prediction of Psychedelics and Non-Psychedelics Via Whole-Brain C-Fos Maps F Aboharb, P Davoudian, LX Shao, J Rondeau, A Sherwood, A Kaye, ... NEUROPSYCHOPHARMACOLOGY 48, 332-332, 2023 | | 2023 |
